Nanoparticles for drug delivery to the lungs.

No abstract is available for this paper.

• Publication year

  2007

• Venue

  Trends in Biotechnology

• Publication date

  2007-12-01

• Fields of study

  Medicine, Materials Science

• Identifiers
  DOI 10.1016/J.TIBTECH.2007.09.005PMID 17997181
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanoparticles--a historical perspective.

  2007cited by this paper
• Effervescent dry powder for respiratory drug delivery.

  2007cited by this paper
• Mechanisms of action of inhaled fibers, particles and nanoparticles in lung and cardiovascular diseases

  2007cited by this paper
• Chitosan nanoparticles are compatible with respiratory epithelial cells in vitro.

  2007cited by this paper
• Inhaling medicines: delivering drugs to the body through the lungs

  2007cited by this paper
• Pulmonary toxicity study in rats with three forms of ultrafine-TiO2 particles: differential responses related to surface properties.

  2007cited by this paper
• Drug release study of large hollow nanoparticulate aggregates carrier particles for pulmonary delivery.

  2007cited by this paper
• Dry powder aerosol delivery of large hollow nanoparticulate aggregates as prospective carriers of nanoparticulate drugs: effects of phospholipids.

  2007cited by this paper
• A brief history of inhaled asthma therapy over the last fifty years.

  2006cited by this paper
• Translocation of Inhaled Ultrafine Manganese Oxide Particles to the Central Nervous System

  2006cited by this paper
• Investigation of the proinflammatory potential of biodegradable nanoparticle drug delivery systems in the lung.

  2006cited by this paper
• Formulation and cytotoxicity of doxorubicin nanoparticles carried by dry powder aerosol particles.

  2006cited by this paper
• Synthesis and characterization of PLGA nanoparticles

  2006cited by this paper
• Single dose and multiple dose studies of itraconazole nanoparticles.

  2006cited by this paper
• Novel Formulation of Large Hollow Nanoparticles Aggregates as Potential Carriers in Inhaled Delivery of Nanoparticulate Drugs

  2006cited by this paper
• A practical approach to the use of nanoparticles for vaccine delivery.

  2006cited by this paper
• Oral delivery of peptide drugs: barriers and developments.

  2005cited by this paper
• The potential advantages of nanoparticle drug delivery systems in chemotherapy of tuberculosis.

  2005cited by this paper
• Dendritic cell subsets and immune regulation in the lung.

  2005cited by this paper
• Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions.

  2005cited by this paper
• Dry Powder Inhalers: An Overview

  2005cited by this paper
• Nanotoxicology: An Emerging Discipline Evolving from Studies of Ultrafine Particles

  2005cited by this paper
• Therapeutic potential of nanoparticulate systems for macrophage targeting.

  2005cited by this paper
• Inhalable alginate nanoparticles as antitubercular drug carriers against experimental tuberculosis.

  2005cited by this paper
• Antitubercular inhaled therapy: opportunities, progress and challenges.

  2005cited by this paper
• Microencapsulated chitosan nanoparticles for lung protein delivery.

  2005cited by this paper
• Novel sustained release microspheres for pulmonary drug delivery.

  2005cited by this paper
• The lungs as a portal of entry for systemic drug delivery.

  2004cited by this paper
• Formulation and characterization of spray-dried powders containing nanoparticles for aerosol delivery to the lung.

  2004cited by this paper
• Toxicological hazards of inhaled nanoparticles--potential implications for drug delivery.

  2004cited by this paper
• Journal of Nanobiotechnology BioMed Central Review Nanoparticles

  2004cited by this paper
• Nanoparticle and targeted systems for cancer therapy.

  2004cited by this paper
• Lectin-functionalized poly (lactide-co-glycolide) nanoparticles as oral/aerosolized antitubercular drug carriers for treatment of tuberculosis.

  2004cited by this paper
• Poly (DL-lactide-co-glycolide) nanoparticle-based inhalable sustained drug delivery system for experimental tuberculosis.

  2003cited by this paper
• Biodegradable nanoparticles for drug and gene delivery to cells and tissue.

  2003cited by this paper
• Polymer degradation and in vitro release of a model protein from poly(D,L-lactide-co-glycolide) nano- and microparticles.

  2003cited by this paper
• Nebulization of biodegradable nanoparticles: impact of nebulizer technology and nanoparticle characteristics on aerosol features.

  2003cited by this paper
• The inhibition of phagocytosis of respirable microspheres by alveolar and peritoneal macrophages.

  2002cited by this paper
• Trojan particles: Large porous carriers of nanoparticles for drug delivery

  2002cited by this paper
• Nebulized Antibiotics in Cystic Fibrosis

  2002cited by this paper
• EXTRAPULMONARY TRANSLOCATION OF ULTRAFINE CARBON PARTICLES FOLLOWING WHOLE-BODY INHALATION EXPOSURE OF RATS

  2002cited by this paper
• TRANSLOCATION OF ULTRAFINE INSOLUBLE IRIDIUM PARTICLES FROM LUNG EPITHELIUM TO EXTRAPULMONARY ORGANS IS SIZE DEPENDENT BUT VERY LOW

  2002cited by this paper
• In vitro and in vivo dose delivery characteristics of large porous particles for inhalation.

  2002cited by this paper
• Biodegradable nanoparticles for drug delivery and targeting

  2002cited by this paper
• Long-circulating and target-specific nanoparticles: theory to practice.

  2001cited by this paper
• Biodegradable polymeric nanoparticles as drug delivery devices.

  2001cited by this paper
• Prolonged hypoglycemic effect of insulin-loaded polybutylcyanoacrylate nanoparticles after pulmonary administration to normal rats.

  2001cited by this paper
• Organic Nanoparticles in the Aqueous Phase-Theory, Experiment, and Use.

  2001cited by this paper
• Influence of formulation excipients and physical characteristics of inhalation dry powders on their aerosolization performance.

  2001cited by this paper
• Freeze-drying of polycaprolactone and poly(D,L-lactic-glycolic) nanoparticles induce minor particle size changes affecting the oral pharmacokinetics of loaded drugs.

  2000cited by this paper
• Aerosol Technology Properties, Behavior, and Measurement of Airborne Particles

  2000cited by this paper
• Optimization of Preparation Techniques for Poly(Lactic Acid-Co-Glycolic Acid) Nanoparticles

  2000cited by this paper
• Physical Characterization of Large Porous Particles for Inhalation

  2000cited by this paper
• Efficacy and safety overview of a new inhaled corticosteroid, QVAR (hydrofluoroalkane-beclomethasone extrafine inhalation aerosol), in asthma.

  2000cited by this paper
• Formulation and Physical Characterization of Large Porous Particles for Inhalation

  1999cited by this paper
• Pulmonary delivery of insulin with nebulized DL-lactide/glycolide copolymer (PLGA) nanospheres to prolong hypoglycemic effect.

  1999cited by this paper
• Recent advances in pulmonary drug delivery using large, porous inhaled particles.

  1998cited by this paper
• Biodegradation and biocompatibility of PLA and PLGA microspheres.

  1997cited by this paper
• Airway deposition and airway effects of antiasthma drugs delivered from metered-dose inhalers.

  1997cited by this paper
• Large porous particles for pulmonary drug delivery.

  1997cited by this paper
• Mechanisms of macromolecule absorption by the lungs

  1996cited by this paper
• Allometric relationships of cell numbers and size in the mammalian lung.

  1992cited by this paper
• Nanoparticle-based dmg delivery systems

  1991cited by this paper
• Deposition of particles in the human respiratory tract in the size range 0.005–15 μm

  1986cited by this paper
• The alveolar macrophage.

  1986cited by this paper
• The normal human lung: ultrastructure and morphometric estimation of diffusion capacity.

  1978cited by this paper
• Morphological basis of alveolar-capillary gas exchange.

  1973cited by this paper
• Architecture of the Human Lung

  1962cited by this paper
• The alveolar macrophage

  1960cited by this paper

• Engineered Spray-Dried PLGA-PEG Dual-Coated Micelles with Lactose/Trehalose Matrices for Pulmonary Doxorubicin Delivery: Achieving Sustained Release and Improved Aerosol Performance in NSCLC Therapy

  2026cites this paper
• Nanoparticle-based inhalation therapy for targeted treatment of multidrug-resistant pulmonary tuberculosis: A review

  2026cites this paper
• Pulmonary Drug Delivery for Infectious Diseases: Cutting-Edge Formulations and Manufacturing Technologies.

  2026cites this paper
• Development of nanoparticle-based Toll-like receptor agonists for respiratory immunotherapy

  2026cites this paper
• Formulation and clinical translation of inhalable nanomedicines for the treatment and prevention of pulmonary infectious diseases

  2025cites this paper
• Impact of hydrogel-based airway management strategies on ventilator-associated pneumonia: clinical applications and future directions

  2025cites this paper
• Innovative approaches to asthma treatment: harnessing nanoparticle technology

  2025cites this paper
• Sulfonium lipid nanoparticles for intranasal mRNA delivery to lung epithelial and immune cells.

  2025cites this paper
• Intranasal drug delivery: reality and prospects

  2025cites this paper
• Precision nanomedicine for pneumonocyte-targeting: Emerging strategies and clinical prospects in refractory pulmonary disease therapy.

  2025cites this paper
• Recent strategies for enhanced delivery of mRNA to the lungs.

  2025cites this paper
• Ultrafine particles deposition in human respiratory tract: Experimental measurement and modeling.

  2025cites this paper
• Unlocking the potential of remdesivir: innovative approaches to drug delivery

  2025cites this paper
• Ultrafine particles: Sources, toxicity, and deposition dynamics in the human respiratory tract -- experimental and computational approaches.

  2025cites this paper
• Charged Particle Dynamics in Dry Powder Inhalers

  2025influential citation
• Inhalable N-Acetylcysteine-loaded Lactose-coated PLGA Nanoparticles for Tuberculosis Treatment

  2025cites this paper
• Organ‐Targeted and Organelle‐Targeted Liposome Gene Vector Construction

  2025cites this paper
• Biocompatible lipid nanovehicles for preventive and therapeutic vaccine development

  2025cites this paper
• Micro- and Nanomotors: Engineered Tools for Targeted and Efficient Biomedicine

  2025cites this paper
• Cyclodextrin-based carriers for targeted drug delivery

  2025cites this paper
• Modern Strategies of Drug Therapy: Multi-Target Drug Delivery, Bioimaging, Diagnostics

  2025cites this paper
• Mechanotransduction for therapeutic approaches: Cellular aging and rejuvenation

  2025cites this paper
• In Silico Investigation of Inhalation Condition Impacts on Hygroscopic Growth and Deposition of Salbutamol Sulphate in Human Airways.

  2024cites this paper
• A review on micro and nanoengineering in Powder-Based pulmonary drug delivery.

  2024cites this paper
• A cationic main-chain poly(carbonate-imidazolium) potent against Mycobacterium abscessus and other resistant bacteria in mice.

  2024cites this paper
• Biopolymeric Inhalable Dry Powders for Pulmonary Drug Delivery

  2024cites this paper
• Supercritical CO2 assisted bioMOF drug encapsulation and functionalization for delivery with a synergetic therapeutic value

  2024cites this paper
• Recent Advances and Clinical Approach to Cancer Treatment with Nanotechnology Derived Biomolecule.

  2024cites this paper
• The therapeutic potential of hemp seed oil as Nasya in the management of insomnia: a literature review

  2024cites this paper
• Nonsmall-cell lung cancer treatment: current status of drug repurposing and nanoparticle-based drug delivery systems

  2024cites this paper
• An aerosol nanocomposite microparticle formulation using Rifampicin-Cyclodextrin inclusion complexes for the treatment of pulmonary diseases.

  2024cites this paper
• Nanoparticle-Based Drug Delivery Systems in Inhaled Therapy: Improving Respiratory Medicine

  2024influential citation
• Nanoengineered polymers and other organic materials in lung cancer treatment: Bridging the gap between research and clinical applications

  2024cites this paper
• Targeting Immune Cells

  2024cites this paper
• Emerging application of nanomedicine-based therapy in acute respiratory distress syndrome.

  2024cites this paper
• Human lung cell cytotoxicity of antibacterial-loaded silica nanoparticles

  2024cites this paper
• “Nano-in-Micro” Structured Dry Powder Inhalers for pulmonary delivery: advances and challenges

  2024cites this paper
• A novel therapeutic outlook: Classification, applications and challenges of inhalable micron/nanoparticle drug delivery systems in lung cancer (Review)

  2024cites this paper
• Inhalable nanomedicine for lung cancer treatment

  2024cites this paper
• Silencing c-myc gene by siRNA delivered by cationic niosomes in MCF-7 cells.

  2024cites this paper
• Lung-Specific mRNA Delivery Enabled by Sulfonium Lipid Nanoparticles.

  2024cites this paper
• Understanding the role of biomolecular coronas in human exposure to nanomaterials

  2024cites this paper
• Enhanced oral and pulmonary delivery of biomacromolecules via amplified transporter targeting.

  2024cites this paper
• Lipidated brush-PEG polymers as low molecular weight pulmonary drug delivery platforms

  2024cites this paper
• Recent Development and Future Aspects: Nano-Based Drug Delivery System in Cancer Therapy

  2024cites this paper
• Muco-adhesive chitosan-coated polyphenol nanoparticle for treatment of infectious acute pneumonia through sustained pulmonary delivery of polymyxin B.

  2024cites this paper
• Nano-Formulations for Pulmonary Delivery: Past, Present, and Future Perspectives

  2024cites this paper
• Lipid sulfoxide polymers as potential inhalable drug delivery platforms with differential albumin binding affinity.

  2024cites this paper
• Therapeutic potential of 18-β-glycyrrhetinic acid-loaded poly (lactic-co-glycolic acid) nanoparticles on cigarette smoke-induced in-vitro model of COPD.

  2024cites this paper
• Inhalable nano-structured microparticles for extracellular matrix modulation as a potential delivery system for lung cancer.

  2024cites this paper
• Revolutionized Drug Delivery by using Pulmonary Nanotechnology: A Review

  2023cites this paper
• Green synthesis by celery seed extract and improvement of the anticancer activity of Quercetin-loaded rGO/Ca1-xMnxFe2O4 nanocarriers using UV light in Breast Cancer Cells

  2023cites this paper
• Long-acting inhaled medicines: Present and future.

  2023cites this paper
• Curcumin Transferosome-Loaded Thermosensitive Intranasal in situ Gel as Prospective Antiviral Therapy for SARS-Cov-2

  2023cites this paper
• Pulmonary drug delivery for acute respiratory distress syndrome

  2023cites this paper
• Cancer treatment and toxicity outlook of nanoparticles.

  2023cites this paper
• Harnessing inhaled nanoparticles to overcome the pulmonary barrier for respiratory disease therapy.

  2023cites this paper
• Dry Powder Inhaler with the technical and practical obstacles, and forthcoming platform strategies.

  2023cites this paper
• Inhalable pH-responsive DNA tetrahedron nanoplatform for boosting anti-tumor immune responses against metastatic lung cancer.

  2023cites this paper
• Nanomedicines: Impactful Approaches for Targeting Pulmonary Diseases.

  2023cites this paper
• Formulation Strategies of Nanosuspensions for Various Administration Routes

  2023cites this paper
• Nebulised delivery of RNA formulations to the lungs: From aerosol to cytosol.

  2023cites this paper
• Emerging Nanotechnology-based Therapeutics: A New Insight into Promising Drug Delivery System for Lung Cancer Therapy.

  2023cites this paper
• Macrophage-targeted lipid nanoparticle delivery of microRNA-146a to mitigate hemorrhagic shock-induced acute respiratory distress syndrome

  2023cites this paper
• Cu,Zn - Superoxide dismutase liposomal dry powder formulations production using supercritical CO2-assisted spray-drying: a proof-of-concept

  2023cites this paper
• Impact of dispersion media and carrier type on spray-dried proliposome powder formulations loaded with beclomethasone dipropionate for their pulmonary drug delivery via a next generation impactor

  2023cites this paper
• Pharmacokinetics and tumor delivery of nanoparticles.

  2023cites this paper
• Fluid-structure interaction analysis of airflow, structural mechanics and aerosol dynamics in a four-generation acinar model

  2023cites this paper
• Fine Particulate Matter Deposition in 3D Out-of-Plane Bifurcation Lung Airway

  2023cites this paper
• Macrophage-Targeted Lipid Nanoparticle Delivery of microRNA-146a to Mitigate Hemorrhagic Shock-Induced Acute Respiratory Distress Syndrome.

  2023cites this paper
• Modeling of street-scale pollutant dispersion by coupled simulation of chemical reaction, aerosol dynamics, and CFD

  2023cites this paper
• PLGA-Based Micro/Nanoparticles: An Overview of Their Applications in Respiratory Diseases

  2023cites this paper
• Construction of mPEI/pGPX4 gene therapeutic system for the effective treatment of acute lung injury

  2023cites this paper
• Optimization of formulation and atomization of lipid nanoparticles for the inhalation of mRNA.

  2023cites this paper
• A comprehensive overview of dry powder inhalers for pulmonary drug delivery: Challenges, advances, optimization techniques, and applications

  2023cites this paper
• Dry Powder Inhalation for Lung Delivery in Cystic Fibrosis

  2023influential citation
• An Insight into Advances in Developing Nanotechnology Based Therapeutics, Drug Delivery, Diagnostics and Vaccines: Multidimensional Applications in Tuberculosis Disease Management

  2023cites this paper
• Inhaled Medicines for Targeting Non-Small Cell Lung Cancer

  2023cites this paper
• Advances and Prospects of Prolamine Corn Protein Zein as Promising Multifunctional Drug Delivery System for Cancer Treatment

  2023cites this paper
• Nano-delivery to the lung - by inhalation or other routes and why nano when micro is largely sufficient?

  2022cites this paper
• Nanocrystals based pulmonary inhalation delivery system: advance and challenge

  2022cites this paper
• Nanomedicines Targeting Respiratory Injuries for Pulmonary Disease Management

  2022cites this paper
• Hybrid chitosan-based nanoparticulate systems for drug delivery

  2022cites this paper
• Dry powders containing chitosan-based nanocapsules for pulmonary administration: Adjustment of spray-drying process and in vitro evaluation in A549 cells

  2022cites this paper
• Recent Developments in Drug Delivery for Treatment of Tuberculosis by Targeting Macrophages

  2022cites this paper
• Development of targeted nanoparticles loaded with antiviral drugs for SARS-CoV-2 inhibition

  2022cites this paper
• Formulation of roselle extract water-in-oil nanoemulsion for controlled pulmonary delivery

  2022cites this paper
• Taking leads out of nature, can nano deliver us from COVID-like pandemics?

  2022cites this paper
• Exposure to Nickel Oxide Nanoparticles Induces Acute and Chronic Inflammatory Responses in Rat Lungs and Perturbs the Lung Microbiome

  2022cites this paper
• Machine Learning Applied to Colloidal Properties of Perfluorocarbon Nanoemulsions for Imaging in ARDS/ALI

  2022cites this paper
• Enhanced curcumin loaded nanocellulose: a possible inhalable nanotherapeutic to treat COVID-19

  2022cites this paper
• The emergence of nanoporous materials in lung cancer therapy

  2022cites this paper
• Advances in Lung Cancer Treatment Using Nanomedicines

  2022cites this paper
• Could the Lung Be a Gateway for Amphotericin B to Attack the Army of Fungi?

  2022cites this paper
• Studies of the Specific Activity of Aerosolized Isoniazid against Tuberculosis in a Mouse Model

  2022cites this paper
• Lactone Stabilized by Crosslinked Cyclodextrin Metal-Organic Frameworks to Improve Local Bioavailability of Topotecan in Lung Cancer

  2022cites this paper
• Nanotechnology as a tool to overcome macromolecules delivery issues.

  2022cites this paper
• Engineering the right formulation for enhanced drug delivery.

  2022cites this paper
• Aerosol deposition in the pulmonary acinar region: Influence of wall motion and interparticle collisions

  2022cites this paper
• Erythro–Magneto–HA–Virosome: A Bio-Inspired Drug Delivery System for Active Targeting of Drugs in the Lungs

  2022cites this paper